About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community

WALTHAM, Mass., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced the launch of the Derek Forfang Patient Advocate Award to recognize passionate supporters of patients living with chronic kidney disease (CKD) who champion the need for innovation and improved health outcomes for patients. This award was established to honor Derek Forfang, an amazing person who suffered from chronic kidney disease and passed away due to issues related to his disease in 2023. Derek was the inspiration and founding member of the Ardelyx Patient Advisory Council, which was just one of the many committees to which Derek belonged. Derek worked tirelessly to improve the lives of patients, families and caregivers in the CKD community. This award serves to recognize individuals who, like Derek, raise awareness of the challenges that kidney patients face, are willing to be the voice for their community and deserve to be recognized for their contributions.

“There are so many individuals, patients, family members and caregivers, who are making incredible efforts to advocate for patients with chronic kidney disease,” said Alan Ryan, DEdMin, Senior Director of Patient Advocacy at Ardelyx. “At Ardelyx, we believe that it is critical to support, celebrate and advance those voices and believe there is no better way to do that than to continue the legacy of our friend and partner, Derek Forfang. There are so many people who are deserving of this recognition, and we encourage everyone in the community to submit a nomination.”

Ardelyx is now accepting nominations for the Derek Forfang Patient Advocate Award. Candidates for the award can be nominated by anyone in the community at large and are considered for the award by the Derek Forfang Patient Advisory Council (DFPAC). To be eligible for the award, nominees must demonstrate achievements and contributions to advocate for CKD patients, which could include raising awareness, educating others, advancing research, advocating for the community and bringing the community together, among many other efforts. Recipients of the Derek Forfang Patient Advocate Award will receive a $1,000 honorarium and a $4,000 donation to be made to a non-profit organization supporting the CKD community.

Nominations can be submitted online at http://ardelyx.com/DFPAAward. The deadline for nominations is January 31, 2025. Full Terms and Conditions for the award can be found at http://ardelyx.com/DFPAAward.

About Ardelyx
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contact:
Caitlin Lowie
clowie@ardelyx.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.